Cargando…
Professional Assessment of the Impact of COVID-19 on Handling NET Patients
The treatment and monitoring of patients with neuroendocrine tumors (NET) has been a major challenge during the COVID-19 pandemic. In a survey, we investigated the influence of COVID-19 on the care of NET patients in the German speaking countries Germany, Austria and Switzerland. The multidisciplina...
Autores principales: | Krug, Sebastian, Garbe, Jakob, König, Senta, Ungewiss, Hanna, Michl, Patrick, Rinke, Anja, Schrader, Jörg |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696769/ https://www.ncbi.nlm.nih.gov/pubmed/33187393 http://dx.doi.org/10.3390/jcm9113633 |
Ejemplares similares
-
Finding the Appropriate Therapeutic Strategy in Patients with Neuroendocrine Tumors of the Pancreas: Guideline Recommendations Meet the Clinical Reality
por: Krug, Sebastian, et al.
Publicado: (2021) -
Updates on Diagnostic and Therapeutic Management of Gastrointestinal and Pancreatic NET
por: Krug, Sebastian, et al.
Publicado: (2022) -
Ramucirumab in combination with dacarbazine in patients with progressive well-differentiated metastatic pancreatic neuroendocrine tumors (RamuNET): study protocol for a multicenter single-arm trial
por: Krug, Sebastian, et al.
Publicado: (2021) -
The Patient’s Point of View: COVID-19 and Neuroendocrine Tumor Disease
por: Krug, Sebastian, et al.
Publicado: (2022) -
Brain metastases in patients with neuroendocrine neoplasms: risk factors and outcome
por: Krug, Sebastian, et al.
Publicado: (2019)